My Profile
Rolfe Winkler
Your guide to
the capital jungle
See all posts
Fri 27 Nov 2009 | 1:24 EST
You are here:
Home
>
Business & Finance
>
Stocks
> Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSS
Widgets
Mobile
Podcasts
Newsletters
Your View
Make Reuters My Homepage
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters
Officers and Directors For Acorda Therapeutics, Inc.
Acorda Therapeutics, Inc. (ACOR.O) (Consolidated Issue listed on NASDAQ Global Market)
sector:
Healthcare
.
industry:
Biotechnology
ยท
View
ACOR
on other exchanges
As of 25 Nov 2009
24.37
USD
Price Change
+0.07
Percent Change
+0.29%
Analyst Recommendations
Research Another Stock:
Symbol Look-up
Independent Research
|
Broker Research
Summary
Biographies
Basic Compensation
Options Compensation
Name
Age
Since
Current Position
Cohen, Ron
53
--
President,Chief Executive Officer, Director
Wasman, Jane
52
2004
Executive Vice President, General Counsel, Secretary
Panem, Sandra
62
1998
Director
Randall, Lorin
65
2006
Director
Rauscher, Steven
55
2005
Director
Young, Wise
59
1995
Director
Greene, Barry
45
2007
Director
Smith, Ian
43
2007
Director
Kelley, John
55
2008
Director
Blight, Andrew
58
2004
Chief Scientific Officer
Wessel, Thomas
53
2008
Chief Medical Officer
Lawrence, David
51
2005
Chief Financial Officer
Find out more about ACOR.O
Insider Trading